Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet

被引：15
|
作者：
Hubacek, Petr [1 ]
Keslova, Petra [1 ]
Formankova, Renata [1 ]
Pochop, Pavel [2 ]
Cinek, Ondrej [3 ]
Zajac, Miroslav [4 ]
Lochmanova, Jana [5 ,6 ]
Stary, Jan [1 ]
Sedlacek, Petr [1 ]
机构：
[1] Charles Univ Prague, Dept Paediat Haematol & Oncol, Sch Med 2, Motol Univ Hosp, CZ-15006 Prague 5, Czech Republic
[2] Charles Univ Prague, Dept Ophthalmol Children & Adults, Sch Med 2, Motol Univ Hosp, CZ-15006 Prague 5, Czech Republic
[3] Charles Univ Prague, Dept Paediat, Sch Med 2, Motol Univ Hosp, CZ-15006 Prague 5, Czech Republic
[4] Charles Univ Prague, Dept Microbiol, Sch Med 2, Motol Univ Hosp, CZ-15006 Prague 5, Czech Republic
[5] Univ Hosp Brno, Ctr Mol Biol & Gene Therapy, Dept Internal Med, Brno, Czech Republic
[6] Masaryk Univ, Brno, Czech Republic
来源：
PEDIATRIC TRANSPLANTATION | 2009年 / 13卷 / 07期
关键词：
cytomegalovirus; transplantation; ganciclovir resistance; cidofovir; foscarnet; PHARMACOKINETIC PROPERTIES; IMMUNOCOMPROMISED PATIENTS; ANTIVIRAL ACTIVITY; THERAPEUTIC USE; GANCICLOVIR; INFECTION;
D O I：
10.1111/j.1399-3046.2008.01070.x
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
We report an 18-yr-old female patient with repeated CMV reactivations after HSCT treated by several pre-emptive courses of virostatic therapy. Seven months after HSCT, she developed CMV encephalitis/retinitis. Initial therapy with GCV and hyperimmune globulin failed, and later on GCV-resistant strain was detected. Continual increase of CMV DNA in peripheral blood led us to combined therapy with CDV and FCV, which was successful and free of severe renal toxicity. To our best knowlegde, this is the first reported case of successful CMV treatment with a combination of CDV and FCV.
引用
收藏
页码：919 / 922
页数：4
相关论文
共 50 条
  • [1] CMV encephalitis/retinitis following allogeneic stem cell transplantation from unrelated donor successfully treated with combination of cidofovir, foscarnet and CMV hyperimmune globulin
    Hubacek, Petr
    Sedlacek, Petr
    Keslova, Petra
    Formankova, Renata
    Zajac, Miroslav
    Lengerova, Martina
    Stary, Jan
    BONE MARROW TRANSPLANTATION, 2008, 42 : S125 - S126
  • [2] Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient
    Poehlmann, Christoph
    Schetelig, Johannes
    Reuner, Ulrike
    Bornhaeuser, Martin
    Illmer, Thomas
    Kiani, Alexander
    Ehninger, Gerhard
    Jacobs, Enno
    Rohayem, Jacques
    CLINICAL INFECTIOUS DISEASES, 2007, 44 (12) : E118 - E120
  • [3] Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis
    Jabs, DA
    Enger, C
    Forman, M
    Dunn, JP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) : 2240 - 2244
  • [4] CMV Retinitis in a Stem Cell Transplant Recipient Treated with Foscarnet Intravitreal Injection and CMV Specific Immunoglobulin
    Vassallo, Francesco
    Busca, Alessandro
    Della Casa, Chiara
    Brunello, Lucia
    Giaccone, Luisa
    Butera, Sara
    Iovino, Giorgia
    De Rosa, Francesco Giuseppe
    Nuzzi, Raffaele
    Cattani, Ilaria
    Bruno, Benedetto
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 507 - 507
  • [5] CMV retinitis in a stem cell transplant recipient treated with foscarnet intravitreal injection and CMV specific immunoglobulins
    Vassallo, Francesco
    Nuzzi, Raffaele
    Cattani, Ilaria
    Dellacasa, Chiara
    Giaccone, Luisa
    De Rosa, Francesco Giuseppe
    Cavallo, Rossana
    Iovino, Giorgia
    Brunello, Lucia
    Bruno, Benedetto
    Busca, Alessandro
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [6] Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients
    Ljungman, P
    Deliliers, GL
    Platzbecker, U
    Matthes-Martín, S
    Bacigalupo, A
    Einsele, H
    Ullmann, J
    Musso, M
    Trenschel, R
    Ribaud, P
    Bornhäuser, M
    Cesaro, S
    Crooks, B
    Dekker, A
    Gratecos, N
    Klingebiel, T
    Tagliaferri, E
    Ullmann, AJ
    Wacker, P
    Cordonnier, C
    BLOOD, 2001, 97 (02) : 388 - 392
  • [7] Epidemiology of cytomegalovirus in allogeneic haematopoietic stem cell transplant recipients
    Moya, R
    Espigado, I
    De la cámara, R
    Rovira, M
    Jarque, I
    Julia, A
    Valera, B
    Herreros, JMC
    BONE MARROW TRANSPLANTATION, 2006, 37 : S183 - S183
  • [8] Cidofovir-induced anterior uveitis in an allogeneic stem cell transplant recipient
    O'Brien, Aine
    Boan, Peter
    TRANSPLANT INFECTIOUS DISEASE, 2022, 24 (06)
  • [9] Successfully treated invasive central nervous system aspergillosis in an allogeneic stem cell transplant recipient
    Z Başlar
    T Soysal
    M Hancı
    G Aygün
    B Ferhanoğlu
    A Çetin Sarioğlu
    B Ülkü
    Bone Marrow Transplantation, 1998, 22 : 404 - 405
  • [10] Successfully treated invasive central nervous system aspergillosis in an allogeneic stem cell transplant recipient
    Baslar, Z
    Soysal, T
    Aygün, G
    Ferhanoglu, B
    Sarioglu, AC
    Ülkü, B
    BONE MARROW TRANSPLANTATION, 1998, 22 (04) : 404 - 405
12345